|Bid||111.85 x 200|
|Ask||111.98 x 300|
|Day's Range||111.47 - 112.59|
|52 Week Range||83.69 - 120.92|
|PE Ratio (TTM)||-0.85|
|Expense Ratio (net)||0.56%|
Biotechnology stock-tracking exchange-traded funds were among the best performers in ETF land Thursday. First Trust NYSE Arca Biotechnology Index (FBT) and SPDR S&P Biotech (XBI) rose more than 1.3% apiece. The iShares Nasdaq Biotechnology ETF (IBB) was further down the list, but still managed to pull out a more than 1% gain.
Amgen (AMGN) stock has risen ~5.8% in 2Q17, while it has risen ~17.4% year-to-date as of July 7, 2017.
Thirteen analysts covered United Therapeutics in June 2017. Two analysts recommended a “strong buy.”